Give Kids a Chance Act of 2023

3/8/2024, 3:54 PM

Summary of Bill S 2897

Bill 118 s 2897, also known as the Give Kids a Chance Act of 2023, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to provide additional support and resources to children in low-income communities in order to improve their educational outcomes and opportunities for success.

The bill proposes several key initiatives to achieve this goal. Firstly, it calls for increased funding for after-school programs, summer learning opportunities, and other extracurricular activities that can help children in underserved communities stay engaged and motivated in their education. Additionally, the bill aims to expand access to high-quality early childhood education programs, such as pre-kindergarten, to ensure that all children have a strong foundation for learning.

Furthermore, the Give Kids a Chance Act of 2023 includes provisions to support teachers and school staff in these communities, such as professional development opportunities and incentives to attract and retain high-quality educators. The bill also emphasizes the importance of parental involvement in children's education and includes measures to increase communication and collaboration between schools and families. Overall, the Give Kids a Chance Act of 2023 seeks to address the disparities in educational opportunities that exist for children in low-income communities and provide them with the support they need to succeed. By investing in programs and initiatives that promote academic achievement and holistic development, this bill aims to give all children a fair chance at a bright future.

Congressional Summary of S 2897

Give Kids a Chance Act of 2023

This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer.

Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.

The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.

Current Status of Bill S 2897

Bill S 2897 is currently in the status of Bill Introduced since September 21, 2023. Bill S 2897 was introduced during Congress 118 and was introduced to the Senate on September 21, 2023.  Bill S 2897's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of September 21, 2023

Bipartisan Support of Bill S 2897

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
6
Democrat Cosponsors
4
Republican Cosponsors
2
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 2897

Primary Policy Focus

Health

Alternate Title(s) of Bill S 2897

Give Kids a Chance Act of 2023Give Kids a Chance Act of 2023A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
Start holding our government accountable!

Comments